615 related articles for article (PubMed ID: 15073264)
21. Evaluation of 18F-CPFPX, a novel adenosine A1 receptor ligand: in vitro autoradiography and high-resolution small animal PET.
Bauer A; Holschbach MH; Cremer M; Weber S; Boy C; Shah NJ; Olsson RA; Halling H; Coenen HH; Zilles K
J Nucl Med; 2003 Oct; 44(10):1682-9. PubMed ID: 14530487
[TBL] [Abstract][Full Text] [Related]
22. Operational lumped constant for FDG in normal adult male rats.
Tokugawa J; Ravasi L; Nakayama T; Schmidt KC; Sokoloff L
J Nucl Med; 2007 Jan; 48(1):94-9. PubMed ID: 17204704
[TBL] [Abstract][Full Text] [Related]
23. Quantitative assessment of cerebral glucose metabolic rates after blood-brain barrier disruption induced by focused ultrasound using FDG-MicroPET.
Yang FY; Chang WY; Chen JC; Lee LC; Hung YS
Neuroimage; 2014 Apr; 90():93-8. PubMed ID: 24368263
[TBL] [Abstract][Full Text] [Related]
24. Whiskers area as extracerebral reference tissue for quantification of rat brain metabolism using (18)F-FDG PET: application to focal cerebral ischemia.
Backes H; Walberer M; Endepols H; Neumaier B; Graf R; Wienhard K; Mies G
J Nucl Med; 2011 Aug; 52(8):1252-60. PubMed ID: 21764786
[TBL] [Abstract][Full Text] [Related]
25. MRS glucose mapping and PET joining forces: re-evaluation of the lumped constant in the rat brain under isoflurane anaesthesia.
Alf MF; Duarte JM; Lei H; Krämer SD; Mlynarik V; Schibli R; Gruetter R
J Neurochem; 2014 May; 129(4):672-82. PubMed ID: 24471521
[TBL] [Abstract][Full Text] [Related]
26. [(18)F]FDG is not transported by P-glycoprotein and breast cancer resistance protein at the rodent blood-brain barrier.
Wanek T; Traxl A; Bankstahl JP; Bankstahl M; Sauberer M; Langer O; Kuntner C
Nucl Med Biol; 2015 Jul; 42(7):585-9. PubMed ID: 25823393
[TBL] [Abstract][Full Text] [Related]
27. Construction and evaluation of multitracer small-animal PET probabilistic atlases for voxel-based functional mapping of the rat brain.
Casteels C; Vermaelen P; Nuyts J; Van Der Linden A; Baekelandt V; Mortelmans L; Bormans G; Van Laere K
J Nucl Med; 2006 Nov; 47(11):1858-66. PubMed ID: 17079820
[TBL] [Abstract][Full Text] [Related]
28. Test-Retest Stability of Cerebral 2-Deoxy-2-[
Sijbesma JWA; van Waarde A; Vállez García D; Boersma HH; Slart RHJA; Dierckx RAJO; Doorduin J
Mol Imaging Biol; 2019 Apr; 21(2):240-248. PubMed ID: 29987619
[TBL] [Abstract][Full Text] [Related]
29. Impact of Image-Derived Input Function and Fit Time Intervals on Patlak Quantification of Myocardial Glucose Uptake in Mice.
Thackeray JT; Bankstahl JP; Bengel FM
J Nucl Med; 2015 Oct; 56(10):1615-21. PubMed ID: 26272811
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and evaluation of nicotine alpha4beta2 receptor radioligand, 5-(3'-18F-fluoropropyl)-3-(2-(S)-pyrrolidinylmethoxy)pyridine, in rodents and PET in nonhuman primate.
Chattopadhyay S; Xue B; Collins D; Pichika R; Bagnera R; Leslie FM; Christian BT; Shi B; Narayanan TK; Potkin SG; Mukherjee J
J Nucl Med; 2005 Jan; 46(1):130-40. PubMed ID: 15632043
[TBL] [Abstract][Full Text] [Related]
31. Simplified quantification of small animal [18F]FDG PET studies using a standard arterial input function.
Meyer PT; Circiumaru V; Cardi CA; Thomas DH; Bal H; Acton PD
Eur J Nucl Med Mol Imaging; 2006 Aug; 33(8):948-54. PubMed ID: 16699768
[TBL] [Abstract][Full Text] [Related]
32. Reproducibility of intraperitoneal 2-deoxy-2-[18F]-fluoro-D-glucose cerebral uptake in rodents through time.
Marsteller DA; Barbarich-Marsteller NC; Fowler JS; Schiffer WK; Alexoff DL; Rubins DJ; Dewey SL
Nucl Med Biol; 2006 Jan; 33(1):71-9. PubMed ID: 16459261
[TBL] [Abstract][Full Text] [Related]
33. Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model.
van Waarde A; Cobben DC; Suurmeijer AJ; Maas B; Vaalburg W; de Vries EF; Jager PL; Hoekstra HJ; Elsinga PH
J Nucl Med; 2004 Apr; 45(4):695-700. PubMed ID: 15073267
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in rat models with hepatocellular carcinoma with liver cirrhosis.
Park SI; Lee JH; Ham HJ; Jung YJ; Park MS; Lee J; Maeng LS; Chung YA; Jang KS
Biomed Mater Eng; 2015; 26 Suppl 1():S1669-76. PubMed ID: 26405933
[TBL] [Abstract][Full Text] [Related]
35. Anesthesia and Preconditioning Induced Changes in Mouse Brain [
Bascuñana P; Thackeray JT; Bankstahl M; Bengel FM; Bankstahl JP
Mol Imaging Biol; 2019 Dec; 21(6):1089-1096. PubMed ID: 30859471
[TBL] [Abstract][Full Text] [Related]
36. Anatomical-based FDG-PET reconstruction for the detection of hypo-metabolic regions in epilepsy.
Baete K; Nuyts J; Van Paesschen W; Suetens P; Dupont P
IEEE Trans Med Imaging; 2004 Apr; 23(4):510-9. PubMed ID: 15084076
[TBL] [Abstract][Full Text] [Related]
37. Searching for alternatives to full kinetic analysis in 18F-FDG PET: an extension of the simplified kinetic analysis method.
Hapdey S; Buvat I; Carson JM; Carrasquillo JA; Whatley M; Bacharach SL
J Nucl Med; 2011 Apr; 52(4):634-41. PubMed ID: 21421718
[TBL] [Abstract][Full Text] [Related]
38. A new tool for molecular imaging: the microvolumetric beta blood counter.
Convert L; Morin-Brassard G; Cadorette J; Archambault M; Bentourkia M; Lecomte R
J Nucl Med; 2007 Jul; 48(7):1197-206. PubMed ID: 17574990
[TBL] [Abstract][Full Text] [Related]
39. Quantification of D2-like dopamine receptors in the human brain with 18F-desmethoxyfallypride.
Gründer G; Siessmeier T; Piel M; Vernaleken I; Buchholz HG; Zhou Y; Hiemke C; Wong DF; Rösch F; Bartenstein P
J Nucl Med; 2003 Jan; 44(1):109-16. PubMed ID: 12515884
[TBL] [Abstract][Full Text] [Related]
40. Repeatable noninvasive measurement of mouse myocardial glucose uptake with 18F-FDG: evaluation of tracer kinetics in a type 1 diabetes model.
Thorn SL; deKemp RA; Dumouchel T; Klein R; Renaud JM; Wells RG; Gollob MH; Beanlands RS; DaSilva JN
J Nucl Med; 2013 Sep; 54(9):1637-44. PubMed ID: 23940301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
